Adenosine Deaminase Activity in Serum and Lymphocytes of Rats Infected with Sporothrix schenckii

Mycopathologia

Volumn 174, Issue 1, 2012, Pages 31-39

  Castro, Verônica S P ^a   Pimentel, Victor C ^a   da Silva, Aleksandro S ^a   Thomé, Gustavo R ^a   Wolkmer, Patrícia ^a   Castro, Jorge L C ^a   Costa, Márcio M ^a   da Silva, Cássia B ^a   Oliveira, Daniele C ^a   Alves, Sydney H ^a   Schetinger, Maria R C ^a   Lopes, Sonia T A ^a   Mazzanti, Cinthia M ^a  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

Author keywords

Adenosine deaminase; Lymphocytes; Serum; Sporotrichosis

Indexed keywords

ADENOSINE DEAMINASE;

ANIMAL; ARTICLE; BLOOD; CHEMISTRY; ENZYMOLOGY; HOST PATHOGEN INTERACTION; IMMUNOLOGY; LYMPHOCYTE; MALE; PATHOGENICITY; PATHOLOGY; RAT; SERUM; SPOROTHRIX; SPOROTRICHOSIS; TIME; WISTAR RAT;

ADENOSINE DEAMINASE; ANIMALS; HOST-PATHOGEN INTERACTIONS; LYMPHOCYTES; MALE; RATS; RATS, WISTAR; SERUM; SPOROTHRIX; SPOROTRICHOSIS; TIME FACTORS;

FUNGI; RATTUS; SPOROTHRIX SCHENCKII;

EID: 84862007357     PISSN: 0301486X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11046-011-9511-x     Document Type: Article

References (53)

1. Schubach A, Barros MB, Wanke B. Epidemic sporotrichosis. Curr Opin Infect Dis. 2008; 1: 129-33.
2. Welsh RD. Sporotrichosis. J Am Vet Med Assoc. 2003; 223: 1123-6.
3. Alves SH, Boettcher CS, Oliveira DC, Tronco-Alves GR, Sgaria MA, Thadeu P, Oliveira LT, Santurio JM. Sporothrix schenckii associated with armadillo hunting in southern Brazil: epidemiological and antifungal susceptibility. Rev Soc Bras Med Trop. 2010; 43: 523-5.
4. Ramos-e-Silva M, Vasconcelos C, Carneiro S, Cestari T. Sporotrichosis. Clin Dermatol. 2007; 25: 181-7.
5. Schubach TM, Schubach A, Okamoto T. Evaluation of an epidemic of sporotrichosis in cats: 347 cases (1998-2001). J Am Vet Med Assoc. 2004; 224: 1623-9.
6. Carlos IZ, Sgarbi DB, Angkuster J, Alvirio CS, Silva CL. Detection of cellular immunity with the soluble antigen of the fungus Sporothrix schenckii in the systemic form of the disease. Mycopathology. 1992; 117: 139-44.
7. Maia DC, Sassa MF, Placeres MC, Carlos IZ. Influence of Th1/Th2 cytokines and nitric oxide in murine systemic infection induced by Sporothrix schenckii. Mycopathology. 2006; 161: 11-9.
8. Burnstock G. Purinergic signalling-an overview. Nov Found Symp. 2006; 276: 26-48.
9. Desrosiers MD, Cembrola KM, Fakir MJ, Stephens LA, Jama FM, Shameli A, Mehal WZ, Shi Y. Adenosine deamination sustains dendritic cell activation in inflammation. J Immunol. 2007; 179: 1884-92.
10. Di Virgilio F. Purinergic p2 × 7receptor: a pivotal role in inflammation and immunomodulation. Drug Dev Res. 1998; 45: 207-13.
11. Luttikhuizen DT, Harmsen MC, de Leij LF, van Luyn MJ. Expression of p2 receptors at sites of chronic inflammation. Cell Tissue Res. 2004; 317: 289-98.
12. Hershfield MS. New insights into adenosine-receptor-mediated immunosuppression and the role of adenosine in causing the immunodeficiency associated with adenosine deaminase deficiency. Europ J Immunol. 2005; 35: 25-30.
13. Franco R, Valenzuela A, Lluis C, Blanco J. Enzymatic and extraenzymatic role of ecto-adenosine deaminase in lymphocytes. Immunol Rev. 1998; 161: 27-42.
14. Aldrich MB, Blackburn MR, Kellems RE. The importance of adenosine deaminase for lymphocyte development and function. Biochem Biophys Res Commun. 2000; 272: 311-5.
15. Bota A, Gella FJ, Profilis C, Ferard G, Hadjivassiliou AG, Horder M, Schiele F, Canalias F. Production and certification of an enzyme reference material for adenosine deaminase 1 (BCR 647). Clin Chim Acta. 2001; 306: 79-89.
16. Antonioli L, Fornai M, Colucci R, Ghisu N, Tuccori M, Del Tacca M, Blandizzi C. Pharmacological modulation of adenosine system: novel options for treatment of inflammatory bowel diseases. Inflamm Bow Dis. 2008; 14: 566-74.
17. Codero O, Salgado F, Fernández-Alonso C, Herrera C, Luis C, Franco R, Nogueira M. Cytokines regulate membrane adenosine deaminase on human activated lymphocytes. J Leukoc Biol. 2001; 70: 920-30.
18. Fröde TS, Medeiros YS. Myeloperoxidase and adenosine-deaminase levels in the pleural fluid leakage induced by carrageenam in the mouse model of pleurisy. Mediators Inflamm. 2001; 10: 223-7.
19. Sharoyan S, Antonyan A, Mardanyan S, Lupidi G, Cristalli G. Influence of dipeptidyl peptidase IV on enzymatic properties of adenosine deaminase. Acta Biochim Polon. 2006; 53: 539-46.
20. Tsuboi I, Sagawa K, Shichijo S, Yokoyama MM, Ou DW, Wiederhold MD. Adenosine deaminase isoenzyme levels in patients with human T-cell lymphotropic virus Type 1 and human immunodeficiency virus Type 1 infections. Clin Diagn Lab Immunol. 1995; 2: 626-30.
21. Iwaki-Egawa S, Yamamoto T, Watanabe Y. Human plasma adenosine deaminase 2 is secreted by activated monocytes. Biol Chem. 2006; 387: 319-21.
22. Kobayashi F, Ikeda T, Marumo F, Sato C. Adenosine deaminase isoenzymes in liver disease. Am J Gastroenterol. 1993; 88: 266-71.
23. Ocana I, Ribera E, Martinez-Vazquez JM, Ruiz I, Bejarano E, Pigrau C, Pahissa A. Adenosine deaminase activity in rheumatoid pleural effusion. Ann Rheum Dis. 1988; 47: 394-7.
24. Erel O, Kocyigit A, Gurel MS, Bulut V, Seyrek A, Ozdemir Y. Adenosine deaminase activities in sera, lymphocytes and granulocytes in patients with cutaneous leishmaniasis. Mem Inst Oswaldo Cruz. 1998; 93: 491-4.
25. Melo FAF, Afiune JB, Santos ML, Castelo Filho A. Diagnóstico da tuberculose pleural pela ADA, isolada ou combinada a outras variáveis, inclusive em HIV-positivos. Folha Méd. 2000; 119: 9-21.
26. Yoshino Y, Kitazawa T, Tatsuno K, Ota Y, Koike K. Cryptococcal pleuritis containing a high level of adenosine deaminase in a patient with AIDS: a case report. Respiration. 2009; 79: 153-6.
27. Beyazit Y, Koklu S, Tas A, Purnak T, Sayilir A, Kurt M, Torun S, Akbal E. Serum adenosine deaminase activity as a predictor of disease severity in ulcerative colitis. J Crohn's Colitis. 2011;. doi: 10. 1016/j. crohns. 2011. 07. 010.
28. Maor I, Rainis T, Lanir A, Lavy A. Adenosine deaminase activity in patients with Crohn's disease: distinction between active and nonactive disease. Eur J Gastroenterol Hepatol. 2011; 23(7): 598-602.
29. Isik S, Karaman U, Kiran TR, Ozer A. Serum adenosine deaminase (ADA) levels in surgically treated hydatid cyst patients. Sci Res Essays. 2011; 6: 3101-2.
30. Atakisi E, Karapehlivan M, Atakisi O, Kontas T, Marasli S. Adenosine deaminase and biochemical liver function tests in the dermatophytic cattle. Bull Vet Inst Pulawy. 2006; 50: 481-3.
31. Pimentel VC, Belle LP, Pinheiro FV, De Bona KS, Da Luz SCA, Moretto MB. Adenosine deaminase activity, lipid peroxidation and astrocyte responses in the cerebral cortex of rats after neonatal hypoxia ischemia. Int J Develop Neurosci. 2009; 27: 857-62.
32. Da Silva AS, Bellé LP, Bitencourt PER, Souza VCG, Costa MM, Oliveira CB, Jaques JA, Leal DBR, Moretto MB, Mazzanti CM, Lopes STA, Monteiro SG. Activity of the enzyme adenosine deaminase in serum, erythrocytes and lymphocytes of rats infected with Trypanosoma evansi. Parasitol. 2011; 138: 201-8.
33. Tonin AA, Pimental VC, Da Silva AS, Azevedo MI, Souza VCG, Wolkmer P, Rezer JFP, Badke MRT, Leal DBR, Schetinger MRC, Monteiro SG, Lopes STA. Adenosine deaminase activity in serum, erythrocytes and lymphocytes of rats infected with Leptospira icterohaemorrhagiae. Res Vet Sci. 2011;. doi: 10. 1016/j. rvsc. 2011. 01. 013.
34. Marimon R, Cano J, Gene J, Sutton DA, Kawasaki M, Guarro J. Sporothrix brasiliensis, S. globosa, and S. mexicana, three new sporothrix species of clinical interest. J Clin Microbiol. 2007; 45: 3198-206.
35. Böyum A. Isolation of mononuclear cells and granulocytes from human blood. J Clin Lab Invest. 1968; 97: 77-89.
36. Giusti G, Gakis C. Temperature conversion factors, activation energy, relative substrate specificity and optimum pH of adenosine deaminase from human serum and tissues. Enzyme. 1971; 12: 417-25.
37. Correa B, Gambale W, Paula CR, Palazzo S. Morphogenesis of Sporothrix schenckii "in vitro" and "in vivo" through the method of viability by fluorescence. Appl Fluoresc Technol. 1991; 3: 1-8.
38. Paes RA. Antígenos e anticorpos na esporotricose: caracterização e aplicações diagnóstico. Mestrado. Rio de Janeiro: Instituto Oswaldo Cruz; 2007. p. 86.
39. Fabrim JJC, Rocha MFG. Micologia Medica: a luz para autores contemporâneos. 1rd ed. Guanabara Koogan; 2004.
40. Madrid IM, Xavier MO, Mattei AS, Fernandes CG, Guim TN, Santin R, Schuch LFD, Nobre MDO, Araújo Meireles MC. Role of melanin in the pathogenesis of cutaneous sporotrichosis. Microbes Infect. 2009; 12: 162-5.
41. Yoshiike T, Lei PC, Komatsuzaki H, Ogawa H. Antibody raised against extracellular proteinases of Sporothrix schenckii in S. schenckii inoculated hairless mice. Mycopathol. 1993; 123: 69-73.
42. González de Polanía LA, Alzate A, Saravia N. Comportamiento experimental del Sporothrix schenckii y la Leishmania mexicana en el hamster. Rev Inst Med Trop. 1990; 32: 319-24.
43. Meinerz ARM, Antunes TA, Silva FV, Xavier MO, Cleff MB, Meireles MCA. Esporotricose experimental sistêmica em ratos Wistar: avaliação hematológica e perfil hepático. Arq Bras Med Vet Zootec. 2008; 4: 1026-8.
44. Caballero ABA, Martínez JC, Rivelli V, Aparicio R, Mendoza G. Esporotricosis en niños: comunicación de tres casos com localización facial. Pediatr. 2000; 27: 32-6.
45. Stockham SL, Scott MA. Fundamentals of veterinary clinical pathology. Ames, Iowa: Blackwell Publishing Company; 2002.
46. Carlos IZ, Sassá MF, Da Graça Sgarbi DB, Placeres MCP, Maia DCG. Current research on the immune response to experimental sporotrichosis. Mycopathol. 2009; 168: 1-10.
47. Bustamante B, Campos PE. Sporotrichosis treatment: overview and update. Curr Fungal Infect Rep. 2011; 5: 42-8.
48. Tachibana T, Matsuyama T, Mitsuyama M. Involvement of CD4 + T cells and macrophages in acquired protection against infection with Sporothrix schenckii in mice. Med Mycol. 1999; 37: 397-404.
49. Ye JH, Rajendran VM. Adenosine: an immune modulator of inflammatory bowel diseases. World J Gastroenterol. 2009; 15: 4491-8.
50. Martinez-Navio JM, Casanova V, Pacheco R, Naval-Macabuhay I, Climent N, Garcia F, Gatell JM, Mallol J, Gallart T, Lluis C, Franco R. Adenosine deaminase potentiates the generation of effector, memory, and regulatory CD4 + T cells. J Leukoc Biol. 2001; 89: 127-36.
51. Abbracchio MP, Ceruti S. P1 receptors and cytokine secretion. Purinergic Signal. 2007; 3: 13-25.
52. Kumar V, Sharma A. Adenosine: an endogenous modulator of innate immune system with therapeutic potential. Eur J Pharmacol. 2009; 616: 7-15.
53. Ungerer JPJ, Oosthuizen HM, Bissbort SH, Vermaak WJH. Serum adenosine deaminase: isoenzymes and diagnostic application. Clin Chem. 1992; 38: 1322-6.